17/04/2020
On the occassion of World Haemophilia Day, read a message from Paul Perreault, CEO of CSL Behring.
17/04/2020
During World Haemophilia Week, we caught up with Sobi's Head of Haematology, Philip Wood.
29/02/2020
Read our newest blog on the occasion of Rare Disease Day on the 29th of February.
12/02/2020
EuropaBio welcomes the foreseen new Circular Economy Action Plan and the plan to publish it with the Industrial Strategy.
04/02/2020
Biotechnology in the fight against cancer - read our newest blog post.
20/01/2020
EuropaBio welcomes the foreseen new Circular Economy Action Plan and the plan to publish it with the Industrial Strategy.
10/10/2019
The John Sime Award for the best innovation presentation delivered at EFIB 2019 was granted to Guillaume Daoulas, Head of Strategic Marketing at Ÿnsect. In the exhibition, a new area was featuring 20 academic posters. The prize of the best academic poster was awarded to Thomas Gassler from the University of Natural Resources and Life Sciences, Vienna.
30/09/2019
As the new European Institutions draw up political guidelines and goals to address climate and sustainability challenges, this year’s conference will highlight the sector’s latest achievements and the potential of a circular bioeconomy for Europe.
28/02/2019
EuropaBio invites EU decision-makers to engage with us and our healthcare biotech members who are leading the field in advanced therapies.
20/02/2019
As the Association representing the European biotechnology industry, EuropaBio is fully committed to the development of a legislative environment which facilitates the creation of EU jobs and growth as well as new solutions to healthcare challenges.
19/02/2019
Read about the outcomes of our working policy breakfast in the European Parliament, hosted by MEPs Claudia Gamon and Tomislav Sokol, in cooperation with ARM, the Alliance for Regenerative Medicine.
16/10/2018
Speakers will call for Europe to continue their commitment to building a sustainable, circular bioeconomy.
11/10/2018
EuropaBio is pleased to welcome the publication of an updated EU Bioeconomy Strategy.
28/05/2018
As an association that has manufacturers of both originator and biosimilar medicines as members, EuropaBio strongly doubts that the promises of today’s Commission proposal outweigh the risks of losing investment in new medicines.
31/03/2018
The European Health Community has warned that time is running out to secure patients’ interests in Brexit negotiations. With Phase 2 of the negotiations looming, health groups across Europe have drawn up a list of crucial unanswered questions that must be answered by the EU and UK negotiators to ‘put patients first’ in the negotiations.
29/11/2017
This document outlines the proposals put forth by EuropaBio members with regard to the changes to the Summary of Product Characteristics (SmPC) of biosimilars, which we consider would result in an enhanced level of transparency in the label.
30/10/2017
Wealth of innovation on display at annual showcase event demonstrates Europe’s strong response to SDG challenges and potential of the circular bioeconomy.
27/09/2017
Possible solutions to improve the European regulatory procedures for clinical trials with Advanced Therapy Medicinal Products consisting of or containing Genetically Modified Organisms
06/06/2017
This document outlines the proposals put forth by EuropaBio members with regard to the changes to the Summary of Product Characteristics (SmPC) of biosimilars, which we consider would result in an enhanced level of transparency in the label.
27/05/2017
This document outlines the proposals put forth by EuropaBio members with regard to the changes to the Summary of Product Characteristics (SmPC) of biosimilars, which we consider would result in an enhanced level of transparency in the label.